Operating Lease, Right-of-Use Asset of HARVARD BIOSCIENCE INC from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
HARVARD BIOSCIENCE INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • HARVARD BIOSCIENCE INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $7,500,000, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

HARVARD BIOSCIENCE INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,500,000 +$977,000 +15% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $7,131,000 +$2,711,000 +61% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $7,283,000 +$2,924,000 +67% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $6,132,000 +$1,359,000 +28% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $6,523,000 +$1,462,000 +29% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $4,420,000 -$833,000 -16% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $4,359,000 -$1,146,000 -21% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $4,773,000 -$1,043,000 -18% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 $5,061,000 -$958,000 -16% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $5,253,000 -$983,000 -16% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $5,505,000 -$1,100,000 -17% 31 Mar 2023 10-Q 26 Apr 2023 2023 Q1
Q4 2022 $5,816,000 -$1,081,000 -16% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $6,019,000 -$1,062,000 -15% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $6,236,000 -$1,005,000 -14% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $6,605,000 -$803,000 -11% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $6,897,000 -$864,000 -11% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $7,081,000 -$846,000 -11% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $7,241,000 -$924,000 -11% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $7,408,000 -$719,000 -8.8% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $7,761,000 -$702,000 -8.3% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $7,927,000 -$570,000 -6.7% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $8,165,000 -$681,000 -7.7% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $8,127,000 -$979,000 -11% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $8,463,000 +$8,463,000 31 Dec 2019 10-K/A 17 Mar 2021 2020 FY
Q3 2019 $8,497,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $8,846,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $9,106,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 08 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.